Intranasal Vaccination with a Lentiviral Vector Strongly Protects against SARS-CoV-2 in Mouse and Golden Hamster Preclinical Models

MLA

Amandine Noirat, et al. Intranasal Vaccination with a Lentiviral Vector Strongly Protects against SARS-CoV-2 in Mouse and Golden Hamster Preclinical Models. July 2020. EBSCOhost, https://doi.org/10.1101/2020.07.21.214049.

APA

Amandine Noirat, Fanny Moncoq, Pierre Charneau, Laleh Majlessi, Jodie Lopez, Philippe Souque, Kirill Nemirov, Fabien Nevo, Pierre Authié, Nicolas Escriou, Maryline Bourgine, Min-Wen Ku, Laurence Fiette, François Anna, Emeline Simon, Hugo Mouquet, Houda Tabbal, Catherine Blanc, Benjamin Vesin, … Annette Martin. (2020). Intranasal Vaccination with a Lentiviral Vector Strongly Protects against SARS-CoV-2 in Mouse and Golden Hamster Preclinical Models. https://doi.org/10.1101/2020.07.21.214049

Chicago

Amandine Noirat, Fanny Moncoq, Pierre Charneau, Laleh Majlessi, Jodie Lopez, Philippe Souque, Kirill Nemirov, et al. 2020. “Intranasal Vaccination with a Lentiviral Vector Strongly Protects against SARS-CoV-2 in Mouse and Golden Hamster Preclinical Models,” July. doi:10.1101/2020.07.21.214049.